Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth.

Cancer letters·2013
Same author

Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth.

Stem cells (Dayton, Ohio)·2012
Same author

Niaspan increases axonal remodeling after stroke in type 1 diabetes rats.

Neurobiology of disease·2012
Same author

Effect of doublecortin on self-renewal and differentiation in brain tumor stem cells.

Cancer science·2011
Same author

MicroRNA-21 protects neurons from ischemic death.

The FEBS journal·2010
Same author

Combination treatment with VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia.

Stroke·2010

Related Experiment Video

Updated: Jun 23, 2026

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
10:53

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions

Published on: November 9, 2020

Bone marrow stromal cells increase oligodendrogenesis after stroke.

Jing Zhang1, Yi Li, Zheng Gang Zhang

  • 1Department of Neurology, Henry Ford Health System, Detroit, Michigan, USA.

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|April 23, 2009
PubMed
Summary

Bone marrow stromal cells (BMSCs) promote recovery after stroke by stimulating oligodendrocyte production. This occurs through activating the Sonic hedgehog (Shh)/Gli1 pathway, crucial for brain repair.

More Related Videos

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
11:11

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning

Published on: February 17, 2016

Generation of Oligodendrocytes and Oligodendrocyte-Conditioned Medium for Co-Culture Experiments
09:05

Generation of Oligodendrocytes and Oligodendrocyte-Conditioned Medium for Co-Culture Experiments

Published on: February 9, 2020

Related Experiment Videos

Last Updated: Jun 23, 2026

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
10:53

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions

Published on: November 9, 2020

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
11:11

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning

Published on: February 17, 2016

Generation of Oligodendrocytes and Oligodendrocyte-Conditioned Medium for Co-Culture Experiments
09:05

Generation of Oligodendrocytes and Oligodendrocyte-Conditioned Medium for Co-Culture Experiments

Published on: February 9, 2020

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Cell Biology

Background:

  • Oligodendrocytes are vulnerable to ischemic injury, impacting brain function.
  • The Sonic hedgehog (Shh) pathway, with Gli1 as its effector, plays a key role in generating new oligodendrocytes.
  • Bone marrow stromal cells (BMSCs) show promise in improving functional recovery after stroke.

Purpose of the Study:

  • To investigate the impact of BMSC treatment on oligodendrogenesis and Shh/Gli1 pathway activation following stroke in a rat model.
  • To determine if BMSCs stimulate the production of oligodendrocytes and myelin in the affected brain regions.
  • To elucidate the role of the Shh/Gli1 pathway in mediating the effects of BMSCs post-stroke.

Main Methods:

  • Middle cerebral artery occlusion (MCAo) model in rats to induce stroke.
  • BMSC transplantation (3 x 10(6) cells) initiated 1 day post-MCAo.
  • Immunohistochemistry and gene expression analysis (mRNA and protein) of oligodendrocytes, myelin, Shh, and Gli1 at 2 and 14 days post-MCAo.
  • In vitro study using N20.1 oligodendrocyte precursor cells treated with BMSCs and a Shh inhibitor (cyclopamine).

Main Results:

  • BMSC treatment significantly increased the number of oligodendrocytes (O4+), myelin basic protein (MBP) expression, and oligodendrocyte progenitor cells (BrdU+, NG2+, BrdU+-NG2+) in the stroke-affected brain.
  • BMSC administration upregulated both mRNA and protein expression of Shh and Gli1 in the ipsilateral hemisphere post-MCAo.
  • In vitro, BMSCs enhanced N20.1 cell proliferation and Gli1 expression, effects blocked by cyclopamine, confirming Shh pathway involvement.

Conclusions:

  • BMSC treatment effectively stimulates oligodendrogenesis and remyelination after ischemic stroke in rats.
  • The therapeutic benefits of BMSCs in stroke appear to be mediated, at least in part, by the activation of the Shh/Gli1 signaling pathway.
  • Targeting the Shh/Gli1 pathway with BMSCs represents a potential therapeutic strategy for stroke recovery.